Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Broad USD Investment Grade Corporate Bond (USIG) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

iShares Broad USD Investment Grade Corporate BondTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

iShares Broad USD Investment Grade Corporate Bond vs Health Care Select Sector SPDR Fund — how do they compare? iShares Broad USD Investment Grade Corporate Bond trades at $50.25, while Health Care Select Sector SPDR Fund trades at $168.42. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.

USIGXLV
Sector
Fixed Income
52-Week High
$52.69$168.44
52-Week Low
$50.18$131.16

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Broad USD Investment Grade Corporate Bond

USIG trades at $50.26, up 0.16% on the day, with a bearish technical signal from moving averages. Recent corporate actions include dividend payments, with the latest being $0.21 per share. The company's subsidiaries maintained credit ratings following a transaction with Tiptree Inc., as noted by AM Best on July 30, 2026.

The outlook is mixed, with technical indicators signaling caution, but institutional interest is present, as Bank of New York Mellon Corp increased its stake. Key risks include market volatility and execution of corporate strategies. The stock presents opportunities for income-focused investors due to dividends, but requires monitoring of fundamental developments.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.

The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Broad USD Investment Grade Corporate Bond

USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.

Read more on USIG

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV